126 related articles for article (PubMed ID: 36725002)
1. Association of Transition of Laboratory Markers with Transition of Disease Activity in Psoriasis Patients Treated with Biologics.
Annen S; Horiguchi G; Teramukai S; Ichiyama S; Ito M; Hoashi T; Kanda N; Saeki H
J Nippon Med Sch; 2022; 89(6):587-593. PubMed ID: 36725002
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: Response to therapy with biologics.
Asahina A; Kubo N; Umezawa Y; Honda H; Yanaba K; Nakagawa H
J Dermatol; 2017 Oct; 44(10):1112-1121. PubMed ID: 28493493
[TBL] [Abstract][Full Text] [Related]
3. The Relationship of Hematological Parameters and C-reactive Protein (CRP) With Disease Presence, Severity, and Response to Systemic Therapy in Patients With Psoriasis.
Şener G; İnan Yuksel E; Gökdeniz O; Karaman K; Canat HD
Cureus; 2023 Aug; 15(8):e43790. PubMed ID: 37731441
[TBL] [Abstract][Full Text] [Related]
4. Blood Cell Biomarkers of Inflammation and Cytokine Levels as Predictors of Response to Biologics in Patients with Psoriasis.
Andersen CSB; Kvist-Hansen A; Siewertsen M; Enevold C; Hansen PR; Kaur-Knudsen D; Zachariae C; Nielsen CH; Loft N; Skov L
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047086
[TBL] [Abstract][Full Text] [Related]
5. A simple tool for evaluation of inflammation in psoriasis: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as markers in psoriasis patients and related murine models of psoriasis-like skin disease.
Kommoss KS; Bieler T; Ringen J; Lehmann A; Mihalceanu S; Hobohm L; Keller K; Brand A; Fischer B; Kramer D; Wild J; Waisman A; Enk A; Schäkel K; Heikenwälder M; Karbach S
J Mol Med (Berl); 2024 Feb; 102(2):247-255. PubMed ID: 38127137
[TBL] [Abstract][Full Text] [Related]
6. Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis.
Kim DS; Shin D; Lee MS; Kim HJ; Kim DY; Kim SM; Lee MG
J Dermatol; 2016 Mar; 43(3):305-10. PubMed ID: 26381893
[TBL] [Abstract][Full Text] [Related]
7. The effect of IL17 and IL23 inhibitors on hematological parameters and C-reactive protein in psoriasis patients.
Esen M
Cutan Ocul Toxicol; 2024 Mar; 43(1):38-45. PubMed ID: 37897439
[TBL] [Abstract][Full Text] [Related]
8. Could Blood Cell-Based Inflammatory Markers Be Used to Monitor Response to Biologic Therapy in Psoriasis?
Kulakli S; Oguz ID; Aksan B
Sisli Etfal Hastan Tip Bul; 2023; 57(4):536-542. PubMed ID: 38268655
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Psoriasis Area and Severity Index as a Proxy for Bio-markers of Systemic Disease under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis: A Retrospective Cohort Study of 186 Treatment Cycles.
Hoffmann JHO; Knoop C; Schäkel K; Enk AH; Hadaschik EN
Acta Derm Venereol; 2021 May; 101(5):adv00462. PubMed ID: 33903917
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil/platelet to lymphocyte ratio in monitoring of response to TNF-α inhibitors in psoriatic patients.
Najar Nobari N; Shahidi Dadras M; Nasiri S; Abdollahimajd F; Gheisari M
Dermatol Ther; 2020 Jul; 33(4):e13457. PubMed ID: 32319132
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment serum neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios: Two tumor-related systemic inflammatory markers in patients with thymic epithelial tumors.
Wang L; Ruan M; Yan H; Lei B; Sun X; Chang C; Liu L; Xie W
Cytokine; 2020 Sep; 133():155149. PubMed ID: 32512341
[TBL] [Abstract][Full Text] [Related]
12. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?
Solmaz Medeni S; Acar C; Olgun A; Acar A; Seyhanlı A; Taskıran E; Sevindik OG; Alacacıoglu I; Piskin O; Ozcan MA; Demirkan F; Undar B; Ozsan GH
Clin Transplant; 2018 Sep; 32(9):e13359. PubMed ID: 30053318
[TBL] [Abstract][Full Text] [Related]
13. Role of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Mean Platelet Volume in Egyptian Patients with Psoriasis Vulgaris.
Hammad R; Hamdino M; El-Nasser AM
Egypt J Immunol; 2020 Jan; 27(1):157-168. PubMed ID: 33180397
[TBL] [Abstract][Full Text] [Related]
14. Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study-the BeNeBio study.
van der Schoot LS; van den Reek JMPA; Grine L; Schots L; Kievit W; Lambert JLW; de Jong EMGJ
Trials; 2021 Oct; 22(1):707. PubMed ID: 34656148
[TBL] [Abstract][Full Text] [Related]
15. Alteration of serum thymus and activation-regulated chemokine level during biologic therapy for psoriasis: Possibility as a marker reflecting favorable response to anti-interleukin-17A agents.
Shibuya T; Honma M; Iinuma S; Iwasaki T; Takahashi H; Ishida-Yamamoto A
J Dermatol; 2018 Jun; 45(6):710-714. PubMed ID: 29655215
[TBL] [Abstract][Full Text] [Related]
16. Impact of Elevated Serum Uric Acid Levels on Systemic Inflammation in Patients With Psoriasis.
Solak B; Dikicier BS; Erdem T
Angiology; 2017 Mar; 68(3):266-270. PubMed ID: 27401209
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers and Predictive Factors for Treatment Response to Tumor Necrosis Factor-α Inhibitors in Patients with Psoriasis.
Hagino T; Saeki H; Kanda N
J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769622
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in Turkish patients with chronic plaque psoriasis.
Polat M; Bugdayci G; Kaya H; Oğuzman H
Acta Dermatovenerol Alp Pannonica Adriat; 2017 Dec; 26(4):97-100. PubMed ID: 29264899
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and other hematological parameters in psoriasis patients.
Wang WM; Wu C; Gao YM; Li F; Yu XL; Jin HZ
BMC Immunol; 2021 Sep; 22(1):64. PubMed ID: 34565327
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-to-lymphocyte ratio may predict subclinical atherosclerosis in patients with psoriasis.
Yurtdaş M; Yaylali YT; Kaya Y; Ozdemir M; Ozkan I; Aladağ N
Echocardiography; 2014 Oct; 31(9):1095-104. PubMed ID: 24447343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
